NCI-N87 [N87] 人胃癌细胞产品图

NCI-N87 [N87] 人胃癌细胞

收藏
  • 询价
  • ATCC传代
  • 美国 中国
  • 2026年09月14日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 供应商:

      复祥生物

    • 细胞类型:

      普通细胞株-科研实验

    • 物种来源:

      人

    • 器官来源:

      胃

    • 运输方式:

      常温

    • 生长状态:

      正常

    • 库存:

      大量

    NCI-N87 [N87] 人胃癌细胞

    RPMI-1640(GIBCO)+10%胎牛血清。细胞货期8-10个工作日

    上海复祥生物提供 ATCC 细胞|细胞系|细胞株|肿瘤细胞|细胞|贴壁细胞|悬浮细胞|,细胞库管理规范,提供的细胞株背景清楚,提供参考文献和最优培养条件,网站上有细胞照片,欢迎各位老师来电咨询!联系电话400-821-8510 手机15000266580
    邮箱xiangfbio@163.com.
    详情请登陆http://www.xiangbio.com/


    CRL-5822 NCI-N87 [N87] 人胃癌细胞
    ATCC® Number: CRL-5822™
    Designations: NCI-N87 [N87]
    Depositors: J Park
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Homo sapiens (human)
    Morphology: epithelial


    Source: Organ: stomach
    Disease: gastric carcinoma
    Derived from metastatic site: liver
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

    Isolation: Isolation date: 1976
    Receptors: acetylcholine, muscarinic, expressed [23078]
    Tumorigenic: Yes
    Oncogene: myc +; erb B2 +
    DNA Profile (STR): Amelogenin: X,Y
    CSF1PO: 8,12
    D13S317: 8,11
    D16S539: 9,13
    D5S818: 12,13
    D7S820: 10,11
    THO1: 9
    TPOX: 9,11
    vWA: 15,16
    Cytogenetic Analysis: near diploid; DM were present in 64% of cells examined
    Gender: male
    Comments: NCI-N87 cells express the surface glycoproteins carcinoembryonic antigen (CEA) and TAG 72, and are L-dopa decarboxylase (DDC) negative. They were minimally positive for vasoactive intestinal peptide (VIP) receptors and lacked gastrin receptors. They were fiound to express receptors for muscarinic cholinergic agents. No evidence of amplification or rearrangements was noted with the N-myc, L-myc, myb and EGF receptor genes. The cell line expressed levels of c-myc and c-erb-B 2 RNA that were comparable to other cell lines.There was no expression of the following genes: N-myc, L-myc, c-cis, IGF-2, or gastrin releasing peptide. NCI-N87 cells have a reported plating efficiency of 4.3%.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
    Atmosphere: air, 95%; carbon dioxide (CO2), 5%
    Temperature: 37.0°C
    Growth Conditions: They grow as an adherent monolayer of tightly knit epithelial cells.
    Subculturing: Protocol:
    Remove and discard culture medium.
    Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
    Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
    Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
    Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
    Add appropriate aliquots of the cell suspension to new culture vessels.
    Incubate cultures at 37°C.

    Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:4 is recommended
    Medium Renewal: Two to three times weekly
    Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
    Storage temperature: liquid nitrogen vapor phase
    Doubling Time: 47 hrs
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
    recommended serum:ATCC 30-2020
    References: 23078: Park JG, et al. Characteristics of cell lines established from human gastric carcinoma. Cancer Res. 50: 2773-2780, 1990. PubMed: 2158397
    23570: . NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996..
    Related Links
    NCBI Entrez Search
    Make a Deposit
    Frequently Asked Questions
    Material Transfer Agreement
    Technical Support
    Related Cell Culture Products

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 细胞推荐 | 常见胃癌细胞系

      人胃癌细胞(未分化) SNL-105 KATO III 人胃癌细胞 SNL-106 NCI-N87 人胃癌细胞 SNL-107 SNU-1 人胃癌细胞 SNL-173 MKN45 人低分化胃癌细胞 SNL-176 MKN74 人胃癌细胞 SNL-304 GES-1 人胃粘膜细胞 SNL-325 Hs-746T 人胃癌细胞 SNL-365 MFC 小鼠胃癌细胞 SNL

    • 细胞名称大汇总

      -N87         人胃癌细胞 3、鸟 类 DT40          鸡淋巴瘤细胞 三、工程细胞系 RKO-E6         人结肠癌转基因细胞    RKO-AS45-1      人结肠癌转基因细胞 PK136          抗小鼠 NK        细胞的杂交瘤细胞 PC 61 5.3        杂交瘤细胞 四、干细胞系 ES-D3(CRL-1934)     小鼠胚胎干细胞      ES-D3(CRL-11632)   小鼠胚胎干细胞

    • 凯基药物筛选中心细胞库目录

      人头颈部肿瘤AM 人腺样囊性癌细胞(高转移)A2 人腺样囊性癌细胞A83 人腺样囊性癌细胞Hep-2 人喉表皮癌细胞KB 人口腔上皮癌细胞CNE-2Z 人鼻咽癌母系细胞肺癌A549 人肺腺癌细胞801-D 人巨细胞性肺癌细胞肺793 肺腺癌细胞H125 人肺癌细胞NCI-H460 人肺癌细胞LTEP-Sm1 人小细胞肺癌细胞(SCLC)消化系统肿瘤 HT-29   人结肠癌细胞 PC-3   人胰腺癌细胞 SW480   人结肠

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1980
    上海酶研生物科技有限公司
    2025年07月16日询价
    询价
    蒂科(上海)生物科技有限公司
    2026年05月29日询价
    ¥2800
    上海彩佑实业有限公司
    2025年07月12日询价
    ¥1800
    上海沪震实业有限公司
    2026年05月29日询价
    NCI-N87 [N87] 人胃癌细胞
    询价